Trinity Biotech directors buy 4.5m company shares

Trinity Biotech today announced that members of its board of directors acquired a total of 4,501,675 ordinary shares in the company by purchasing stock on the open market and exercising share options.

Trinity Biotech today announced that members of its board of directors acquired a total of 4,501,675 ordinary shares in the company by purchasing stock on the open market and exercising share options.

Chairman and CEO Ronan Ó Caoimh purchased 1,750,800 shares in the open market and exercised 1,070,000 options.

President Brendan Farrell purchased 10,000 shares and exercised 526,875 options. COO Jim Walsh purchased 184,000 shares and exercised 750,000 options.

CFO Rory Nealon exercised 200,000 options and non-executive director Denis Burger purchased 10,000 shares.

Mr Ó Caoimh said: “These transactions reflect the confidence and belief that the senior executives and board of the company have in the future of Trinity Biotech.”

Trinity Biotech is a developer and manufacturer of medical devices, which is listed on the ISEQ and the NASDAQ.

More in this section

The Business Hub
Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Sign up
Puzzles logo
IE-logo

Puzzles hub

Visit our brain gym where you will find simple and cryptic crosswords, sudoku puzzles and much more. Updated at midnight every day.

Lunchtime
News Wrap

A lunchtime summary of content highlights on the Irish Examiner website. Delivered at 1pm each day.

Sign up
Revoiced
Newsletter

Our Covid-free newsletter brings together some of the best bits from irishexaminer.com, as chosen by our editor, direct to your inbox every Monday.

Sign up